Legend Biotech (LEGN)
(Delayed Data from NSDQ)
$34.01 USD
-1.15 (-3.27%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $33.98 -0.03 (-0.09%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Legend Biotech Corporation Sponsored ADR has a market cap of $6.49B, which represents its share price of $35.16 multiplied by its outstanding shares number of 184.57M. As a mid-cap company, LEGN's shareholders are generally exposed to less risk than shareholders of small-cap companies but more risk than large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
LEGN 34.01 -1.15(-3.27%)
Will LEGN be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for LEGN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for LEGN
Company News for Aug 12, 2025
Key Inflation Data in Focus
LEGN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Pre-Markets in Green, Inflation Data, Retail Sales, Q2 Earnings This Week
Legend Biotech (LEGN) Surges 6.0%: Is This an Indication of Further Gains?
What Makes Legend Biotech (LEGN) a New Buy Stock
Other News for LEGN
Is LEGN lining up for a decline? Fell Below 20 Day Moving Average shows up after declining 3.27%
Is LEGN building bullish momentum? Crossed Above 20 Day Moving Average shows up after rising 2.0%
20 Day Moving Average Resistance appears for LEGN after 0.38% move
Is LEGN preparing to trend higher? MACD Bullish Signal Line Cross shows up after advancing 1.36%
Stochastic Buy Signal appears for LEGN after 2.33% move